Early suppressive effects of chemotherapy and cytokine treatment on committed versus primitive haemopoietic progenitors in patient bone marrow

British Journal of Haematology

Volumn 92, Issue 3, 1996, Pages 537-547

  Schwartz, G N ^a   Hakim, F ^a   Zujewski, J ^a   Szabo, J M ^a   Cepada, R ^a   Riseberg, D ^a   Warren, M K ^b   Mackall, C L ^a   Setzer, A ^a   Noone, M ^a   Cowan, K H ^a   O'shaughnessy, J ^a   Gress, R E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

Author keywords

Bone marrow long term cultures; CD34+ cells; Colony forming units for granulocytes and macrophages; GM CSF; PIXY321

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MILODISTIM; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ARTICLE; BONE MARROW SUPPRESSION; BREAST CANCER; CLINICAL ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 9044249723     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.00387.x     Document Type: Article

References (49)

1. Aglietta, M., Bussolino, F., Piacibello, W., Apra, F., Sanavio, F., Stacchini, A., Monzeglio, C., Carnino, F. & Gavosto, F. (1990) Human GM-CSF in vivo: identilication of the target cells and of their kinetics of response. International Journal of Cell Cloning, 8, (Suppl. 1), 283-290.
2. Aglietta, M., Sanavio, F., Stacchini, A., Morelli, S., Fubini, L., Severino., A., Pasquino, P., Volt, C., Bretti, S., Tafuto, S., Zola, P., Sismondi, P., Sklenar, I., Piacibello, W., Bussolino, F. & Gavosto, F. (1993) Interleukin-3 in vivo: kinetic of response of target cells. Blood, 82, 2054-2061.
3. Albin, N., Douay, L., Fouillard, L. Laporte, J.P., Isnard, F., Lesage, S., Ozsahin, H., Bardinet, D., Najman, A. & Gorin, N.C. (1994) In vivo effects of GM-CSF and IL-3 on hematopoietic cell recovery in bone marrow and blood after autologous transplantation with mafosfamide-purged marrow in lymphoid malignancies. Bone Marrow Transplantation, 14, 253-259.
4. Anderson, J.E. & Appelbaum, F.R. (1994) Hemopoietic effects and clinical uses of granulocyte-macrophage colony-stimulating factor and PIXY321. Current Opinion in Hematology, 1, 203-209.
5. Baum, S.J. (1967) A measure of nonreparable injury to hematopoietic stem cells in rats exposed repeatedly to X-rays. Radiation Research, 32, 651-657.
6. Betticher, D.C., Huxol, H., Muller, R., Speck, B. & Nissen, C. (1993) Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia. Experimental Hematology, 21, 1517-1521.
7. Bhavnani, M., Morris-Jones, P.H. & Testa, N.G. (1989) Children in long-term remission after treatment for acute lymphoblastic leukaemia show persisting haemopoietic injury in clonal and long-term cultures. British Journal of Haematology, 71, 37-41.
8. Bishop, J.F (1994) Platelet support and the use of cytokines. Stem Cells, 12, 370-377.
9. Branuschweiger, P.G., Schenken, L.L. & Schiffer, L.M. (1980) Adriamycin-induced delayed erythropoietic injury expressed following anemia stress. Cancer Research, 40, 2257-2262.
10. Broxmeyer, H.E., Benninger, L., Cooper, S., Hague, N., Benjamin, R.S. & Vadhan-Raj. S. (1995) Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma. Experimental Hematology, 23, 335-340.
11. Broxmeyer, H.E., Cooper, S., Williams, D.E., Hangoc, G., Gutterman, J.U. & Vadhan-Raj, S. (1988) Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with pruified reeombinant human granulocyte-macrophage colony-stimulating factor. Experimental Hematology, 16, 594-602.
12. Caux, C., Favre, C., Saeland, S., Duvert, V., Durand, I., Mannoni, P. & Banchereau, J. (1990) Potentiation of early hematopoiesis by tumor necrosis factor-α is followed by inhibition of granulopoietic differentiation and proliferation. Blood, 75, 2292-2298.
13. Cheung, N.K.V. & Heller, G. (1991) Chemotherapy dose intensity correlates strongly with response, median survival and median progression-free survival in metastatic neuroblastoma. Journal of Clinical Oncology, 9, 1050-1058.
14. Civin, C.I. & Gore, S.D. (1993) Antigenic analysis of hematopoiesis: a review. Journal of Hematotherapy, 2, 137-144.
15. Cohen, G.I., Greenberger, J.S. & Canellos, G.P. (1982) Effect of chemotherapy and irradiation on interactions between stromal and hemopoietic cells in vitro. Scanning Electron Microscopy, 1. 359-365.
16. Coulombel, L., Eaves, A.C. & Eaves, C.J. (1983) Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer. Blood, 62, 291-297.
17. Fisher, D.C. & Peters, W.P. (1994) Advances in the clinical use of granulocyte colony-stimulating factor and granulocyte-macrophage stimulating factor to intensify cancer chemotherapy. Current Opinion in Hematology, 1, 221-227.
18. Gazzola, M-V., Collins, N.H., Tafuri, A. & Keever, C.A. (1992) Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow. Experimental Hematology, 20, 201-208.
19. Greenberger, J.S. (1991) Toxic effects on the hematopoietic microenvironment. Experimental Hematology, 19, 1101-1109.
20. high cells. Blood, 82, 3283-3289.
21. Hart, P.H., Whitty, G.A., Burgess, D.R. & Hamilton, J.A. (1990) Regulation by interleukin-3 of human monocyte pro-inflammatory mediators: similarities with granulocyte-macrophage colony-stimulating factor. Immunology, 71, 76-82.
22. Herrmann, F., Bambach, T., Bonifer, R., Lindemann, A., Riedel, D., Oster, W. & Mertelsmann, R. (1988) The suppressive effects of recombinant human TNF on normal and malignant hematopoiesis: synergisms with interferon gamma. International Journal of Cell Cloning, 6, 241-261.
23. Hyrniuk, W.M., Levine, M.N. & Levine, L. (1986) NCI Monographs Number 1. Proceedings of the NIH Consensus Development Conference on Adjuvant Chemotherapy and Endocrine Therapy for Breast Cancer, CTR Consensus, pp. 87-94.
24. Johnsen, H.E., Jensen, L., Gaarsdal, E., Hansen, P.B., Ersboll, J. & Hansen, N.E. (1994) Priming with recombinant human hematopoietic cytokines before bone marrow harvest expands in vivo and enhances ex vivo recovery of myeloid progenitors in short-term liquid cultures. Experimental Hematology, 22, 80-86.
25. Kinniburgh, D. & Russell, N.H. (1993) Comparative study of CD34-positive cells and subpopulations in human umbilical cord blood and hone marrow. Bone Marrow Transplantation, 12, 489-494.
26. Marsh, J.C. (1976) The effects of cancer chemotherapeutic agents on normal hematopoietic precursor cells: a review. Cancer Research, 36, 1853-1882.
27. Mukai, J., Shimizu, E., Takaue, Y. & Ogura, T. (1992) Effect of chemotherapy on colony-forming unit-granulocyte macrophage from bone marrow and peripheral blood in patients with lung cancer. Oncology, 49, 45-48.
28. Neben, S., Hemman, S., Montgomery, M., Ferrara, J. & Mauch, P. (1993) Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents. Experimental Hematology, 21, 156-162.
29. Orazi, A., Cattoretti, G., Schiro, R., Siena, S., Bregni, M., Di Nicola, M. & Gianni, A.M. (1992) Recombinant human interleukin-3 and recombinant granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrow. Blood, 79, 2610-2619.
30. O'Reilly, R., Gillio, A. & Gasparetto, C. (1990) Effects of hematopoietic growth factors following myeloblation in a primate model. International Journal of Cell Cloning, 8. (Suppl. 1). 262-269.
31. Rabinowitz, J., Petros, W.P., Stuart, A.R. & Peters, W.P. (1993) Characterization of endogenous cytokine concentrations after high-dose chemotherapy with autologous bone marrow support. Blood, 81, 2452-2459.
32. Radford, J.A., Testa, N.G. & Growther, D. (1990) The long term effects of MVPP chemotherapy for Hodgkins disease on bone marrow function. British Journal of Cancer, 62, 127-132.
33. Reisbach, G., Bartke, I., Kempkes, B., Kostka, G., Ellwart, J., Birner, A., Thalmeier, K., Mailbammer, R., Bornkamm, G.W., Ullrich, A. & Dormer, P. (1993) Characterization of hemopoietic cell populations from human cord blood expressing c-kit. Experimental Hematology, 21, 74-79.
34. Rice, A., Reiffers, J., Bernard, P., Foures, C., Bascans, E., Lacombe, F., Marit, G. & Broustet, A. (1992) Incomplete stroma formation after allogeneic marrow or autologous blood stem cell transplantation. Nouvelle Revue Française d'Hematologie, 34, 167-174.
35. + hematopoietic cells. Experimental Hematology, 20, 24-33.
36. Schmitz, L.L., McClure, J.S., Litz, C.E., Dayton, V., Weisdorf, D.J., Parkin, J.L. & Brunning, R.D. (1994) Morphologic and quantitative changes in blood and marrow cells following growth factor therapy. American Journal of Clinical Patholology, 101, 67-75.
37. Schwartz, G.N. (1989) Use of Gel-Well culture chambers as a liquid culture system to measure responses of hematopoietic colony-forming cells to growth factors. International Journal of Cell Cloning, 7, 360-372.
38. Schwartz, G.N., Kessler, S.W., Rothwell, S.W., Burrell, L.M., Reid, T.J., Meltzer, M.S. & Wright, D.G. (1994) Inhibitory effects of HIV-1-infected stromal cell layers on the production of myeloid progenitor cells in human long-term bone marrow cultures. Experimental Hematology, 22, 1288-1296.
39. Seipelt, G., Ganser, A., Duranceyk, H., Maurer, A., Ottmann, O.G. & Hoelzer, D. (1993) Induction of TNF-α in patients with myelodysplastic syndromes undergoing treatment with IL-3. British Journal of Haematology, 84, 749-751.
40. Sisson, S.D. & Dinarello, C.A. (1988) Production of interluekin-1α. interluekin-β and tumor necrosis factor by human mononuclear cells stimulated with granulocyte-macrophage colony-stimulating factor. Blood, 72, 1368-1374.
41. Sokal, R.R. & Rohlf, F.J. (1995) Biometry: the Principles and Practice of Statistics in Biological Research, pp. 427-431. W. H. Freeman and Company, New York.
42. Sprent, P. (1989) Applied Nonparametric Statistical Methods. pp. 87-93. Chapman and Hall, New York.
43. Sutherland, H.J., Eaves, A.C. & Eaves, C.J. (1991) Quantitative assays for human hemopoietic progenitor cells. Bone Marrow Processing and Purging (ed. by A. P. Gee), pp. 155-171. CRC Press, Boston.
44. Tarella, C., Caracciolo, D., Gavarotti, P., Bondesan, P., Herasco, C., Omede, P., Bregni, M., Siena, S., Gianni, A.M. & Pileri, A. (1995) Circulating progenitors following high-dose sequential (HDS) chemotherapy with G-CSF: short intervals between drug courses severely impair progenitor mobilization. Bone Marrow Transplantation, 16, 223-228.
45. + CD38 progenitor cells. Blood, 77, 1218-1227.
46. Vadhan-Raj, S. (1994) PIXY321 (GM-CSF/IL-3 fusion protein): biology and early clinical development. Stem Cells, 12, 253-261.
47. - cells selected from macrophage inflammatory protein 1α + interleukin-3-supplemented 'stroma-noncontact' cultures are highly enriched for long-term bone marrow culture initiating cells. Blood, 84, 1442-1449.
48. Worton, R.G., McCulloch, E.A. & Till, J.E. (1969) Physical separation of hemopoietic stem cells from cells forming colonies in culture. Journal of Cellular Physiology, 74, 171-182.
49. Yamaguchi, Y., Gunji, Y., Nakamura, M., Hayakawa, K., Maeda, M., Osawa, H., Nagayoshi, K., Kashara, T. & Suda, T. (1993) Expression of c-kit mRNA and protein during differentiation of human hematopoietic progenitor cells. Experimental Hematology, 21, 1233-1238.